Showing 531-540 of 3058 results for "".
Diagnosing and Treating Co-morbid Sleep Apnea in Neurological Disorders, Part II
https://practicalneurology.com/diseases-diagnoses/sleep/diagnosing-and-treating-co-morbid-sleep-apnea-in-neurological-disorders-part-ii/30837/It is crucial for physicians to identify sleep apnea when it co-exists with common neurologic conditions and to be prepared to offer effective interventions.Neuromyelitis Optica Spectrum Disorder in Castleman Disease
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/neuromyelitis-optica-spectrum-disorder-in-castleman-disease/32104/A novel case report involving two rare clinical entities.Drugs in Development for Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/drugs-in-development-for-multiple-sclerosis/31632/Stem cells, tyrosine kinase inhibitors, remyelinating agents, metabolically active molecules, and more are being tested as potential new disease-modifying treatments.Movement Disorders Moment: Neurodegenerative Spinocerebellar Ataxia
https://practicalneurology.com/diseases-diagnoses/child-neurology/movement-disorders-moment-neurodegenerativespinocerebellar-ataxia/31544/Can we do better than localizing the lesion?Migraine With Nonvisual Aura
https://practicalneurology.com/diseases-diagnoses/headache-pain/migraine-with-nonvisual-aura/31900/Better understanding of nonvisual auras helps with diagnosis, treatment, and patient education regarding symptoms that can be alarming.HyperCKemia
https://practicalneurology.com/diseases-diagnoses/imaging-testing/hyperckemia/31550/Evaluation for elevated creatine kinase is a required skill for neurologists.Letters
https://practicalneurology.com/columns/practice-management/letters/30698/Monoclonal Antibodies and Migraine: What the Neurologist Needs to Know
https://practicalneurology.com/diseases-diagnoses/headache-pain/monoclonal-antibodies-and-migraine-what-the-neurologist-needs-to-know/30361/As a new age in headache medicine is set to begin, it is incumbent upon neurologists to become better familiarized with and explore the implications of monoclonal antibodies in patient care.Movement Disorders Moment: Parkinson Disease in the COVID-19 Era
https://practicalneurology.com/diseases-diagnoses/movement-disorders/movement-disorders-moment-parkinson-disease-in-the-covid-19-era/31774/The pandemic has risks for people with Parkinson disease both from COVID-19 and effects of the lockdown and raises questions about future risk of parkinsonism.Prognostic Factors in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/prognostic-factors-in-multiple-sclerosis/31874/Prediction of highly active disease and rapid disability accumulation is crucial to optimizing clinical outcomes over time.